Program Goals

Click here to register for this event

The purpose of this educational activity is to examine the status and application of evidence-based individualized patient therapy utilizing companion diagnostics. Oncology-specific challenges will be discussed relative to practical use of companion diagnostics to guide targeted pharmacologic therapy.

Target Audience

The target audience will be specialists in Internal Medicine including but not limited to those with sub-specialties in Medical Oncology.

Educational Objectives

Upon completion of this activity participants should be able to:

 1. Summarize the progress in pharmacogenomics, with emphasis on use in oncology.

 2.   Describe the specific challenges in oncology for developing pharmacogenomic markers and        companion dx tests. 

 3.  Discuss the range of companion diagnostic tests currently available to the molecular pathologist. 

 4.  Identify cancers where evidence-based companion diagnostics are utilized by the clinician to guide the use of targeted oncologic therapies.  

Faculty

DrRattan.jpg

Mark J. Ratain  MD
Professor of Medicine,
Director: Center for Personalized Therapeutics
Associate Director for Clinical Sciences,
Comprehensive Cancer Center 
The University of Chicago Medicine, Chicago, Illinois

 

DrHalling.jpg

Kevin C. Halling  MD  PhD
Associate Professor
Department of Laboratory Medicine and Pathology
Mayo Clinic, Rochester, Minnesota

DrDancey.jpg

 

Janet Dancey  MD
Director, Clinical Translational Research,
NCIC Clinical Trials Group

Professor, Department of Oncology
Queen’s University, Kingston, Ontario, Canada

Educational Activity Agenda

- 105 minutes: Course Instructive Materials and Faculty Discussion
- 15 minutes: Conclusion; FAQs; Credit Application Info

Release and Expiration Dates

 CME ACCREDITATION FOR THIS ACTIVITY HAS EXPIRED

Enduring Archive CME Release Date: December 15, 2012
Enduring Archive CME Expiration Date: December 15, 2013

 

 

Disclosure Information

As a sponsor accredited by the ACCME, the EOCME requires anyone who is in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past twelve months, including financial relationships of a spouse or life partner, that could create a conflict of interest. 

The EOCME encourages speakers and authors to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration, at first mention and where appropriate in the content or during the presentation.

Faculty Disclosures

  Name   Type   Commercial Supporter
 Mark J. Ratain, MD  Nothing to disclose  Nothing to disclose
 Kevin C. Halling, MD, PhD  Grant / Research Support  Abbott
 Royalty

 Patent / Co-inventor
 UroVysion™ probe: Abbott

 Janet Dancey, MD  Nothing to disclose  Nothing to disclose

Planners and Managers

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

ELSEVIER OFFICE OF CONTINUING MEDICAL EDUCATION
PLANNER OR MANAGER FINANCIAL RELATIONSHIP
Sandy Breslow Nothing to disclose

DANE GARVIN LTD.
PLANNER OR MANAGER FINANCIAL RELATIONSHIP
LaRue Highsmith Nothing to disclose
Geoff Lowe Nothing to disclose

Physician Accreditation Statement - CME

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Elsevier Office of Continuing Medical Education (EOCME) and Dane Garvin Ltd. (DGL).  EOCME is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation - CME

The EOCME designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Elsevier Office of Continuing Medical Education

For information about the physician accreditation of this activity, please contact us at elseviercme@elsevier.com.

How to Obtain CME Credit

Attendees are expected to view all presentations before attempting to take the test and/or complete the activity evaluation. Successful completion will lead to the issuance of a certificate for AMA PRA Category 1 Credits™. To receive credit, the course must be completed between December 15, 2012 and December 15, 2013 now expired.

Participation in this activity should be completed in approximately 2.0 hours. Please follow these steps in order to receive CME credit for viewing the webcast:

  • Read all of the CME accreditation information above.
  • View the complete webcast program.
  • Click on the link to apply for CME credits.
  • Complete the online registration (registration is free).
  • Complete the online test and/or evaluation. Participants must receive a test score of at least 75% and answer all evaluation questions to receive a certificate.

After successfully completing the online test and/or evaluation, your application will be immediately processed and you will be given the opportunity to download a personalized CME certificate for participation in this activity. 

Should you have any CME questions regarding this activity, please contact:

Elsevier Office of Continuing Medical Education
1600 John Fr. Kennedy Blvd., Suite 1800
Philadelphia, PA 19103
Phone: 267-362-5288
Fax: 877-771-9237
Email: elseviercme@elsevier.com
Web: www.elseviercme.com

 

Lab Professional Credit Designation - P.A.C.E.®

The American Society for Clinical Laboratory Science's Professional Acknowledgment for Continuing Education (P.A.C.E.®) Program will provide 2.0 contact hours of credit.

How to Obtain P.A.C.E.® Credit

PACE_Logo.jpg

Viewers are expected to complete the presentation before attempting to submit contact information and the session evaluation. Successful completion will lead to the issuance of a certificate for 2.0 contact hours of P.A.C.E.® approved continuing education. To receive credit, the course must be completed between  December 15, 2012 and December 15, 2014.

Participation in this activity should be completed in approximately 2.0 hours. Please follow these steps in order to receive P.A.C.E.® credit for viewing the enduring material:

  • Read all of the information above.
  • View the complete enduring material.
  • Click on the "Lab Professional" link to apply for P.A.C.E.® credit.
  • Complete the online registration (registration is free).
  • Complete the online test and/or evaluation. Participants must receive a test score of at least 70% and answer all evaluation questions to receive P.A.C.E.® credit. 
  • After successful completion of this process, you will be redirected to the ASCLS CE Organizer where you may create and print an official ASCLS P.A.C.E.® certificate based on your attendance and completion of this ASCLS-sponsored P.A.C.E.® approved learning activity.

Should you have any P.A.C.E.® questions regarding this activity, please contact:
ASCLS P.A.C.E.®
1861 International Drive, Suite 200
Tysons Corner, VA 22102
Ph: 571-748-3776
Fx: 571-354-7576
http://www.ascls.org/

P.A.C.E.® Release and Expiration Dates

Enduring Archive PACE Release Date: December 15, 2012
Enduring Archive PACE Expiration Date: December 15, 2014

Fee Information

There is no fee for this educational activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents and/or laboratory tests that are not approved or cleared by the FDA. The Elsevier Office of Continuing Medical Education (EOCME) does not recommend the use of any agents and/or laboratory tests outside of labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Policy on Privacy and Confidentiality

The Elsevier Office of Continuing Medical Education (EOCME) protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. EOCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

EOCME and Dane Garvin Ltd. maintain physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Medium Used

This program has been made available online.
“Personalized Medicine: Molecular Diagnostics and Targeted Therapies for Cancer” 

System Requirements

To view this educational activity you will need a web browser with Javascript and either Flash or HTML5 enabled.  Nearly all modern web browsers will work.

Academic Cosponsor

AMPLogo8282012.png  This activity is academically cosponsored by the Association for Molecular Pathology.

Commercial Support Statement

3a_Qiagen_Logo_30mm_RGB_regist.jpgThis activity is supported by an educational grant from QIAGEN.

Copyright

Copyright©  2012 Dane Garvin, Ltd. All Rights Reserved.   Permission for accreditation use granted to the Elsevier Office of Continuing Medical Education (EOCME).